Published in J Clin Oncol on June 01, 1999
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature (2011) 13.53
Osteosarcoma development and stem cell differentiation. Clin Orthop Relat Res (2008) 2.18
Prognostic significance of serum S100B protein in high-risk surgically resected melanoma patients participating in Intergroup Trial ECOG 1694. J Clin Oncol (2008) 1.19
Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis. Br J Cancer (2012) 1.19
Biomarkers in melanoma. Ann Oncol (2009) 1.17
Serum microRNAs as biomarkers for recurrence in melanoma. J Transl Med (2012) 1.06
Computational algorithm-driven evaluation of monocytic myeloid-derived suppressor cell frequency for prediction of clinical outcomes. Cancer Immunol Res (2014) 1.06
Phyllanthus spp. induces selective growth inhibition of PC-3 and MeWo human cancer cells through modulation of cell cycle and induction of apoptosis. PLoS One (2010) 1.05
LC/MS-based quantitative proteomic analysis of paraffin-embedded archival melanomas reveals potential proteomic biomarkers associated with metastasis. PLoS One (2009) 1.05
Diagnosing melanoma patients entering American Joint Committee on Cancer stage IV, C-reactive protein in serum is superior to lactate dehydrogenase. Br J Cancer (2004) 1.02
The extracellular human melanoma inhibitory activity (MIA) protein adopts an SH3 domain-like fold. EMBO J (2001) 1.01
Diagnostic and prognostic biomarkers in melanoma. J Clin Aesthet Dermatol (2014) 0.98
Serum S100B, lactate dehydrogenase and brain metastasis are prognostic factors in patients with distant melanoma metastasis and systemic therapy. PLoS One (2013) 0.97
Differential gene expression profiles of gastric cancer cells established from primary tumour and malignant ascites. Br J Cancer (2002) 0.93
Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies. Arch Dermatol Res (2007) 0.92
Proteomics in melanoma biomarker discovery: great potential, many obstacles. Int J Proteomics (2011) 0.92
A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients. Oncotarget (2015) 0.88
Serum CEACAM1 Correlates with Disease Progression and Survival in Malignant Melanoma Patients. Clin Dev Immunol (2012) 0.86
The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis. EBioMedicine (2015) 0.84
A synopsis of serum biomarkers in cutaneous melanoma patients. Dermatol Res Pract (2012) 0.84
Highly sensitive detection of melanoma based on serum proteomic profiling. J Cancer Res Clin Oncol (2009) 0.83
Changes in the gene expression profile of A375 human melanoma cells induced by overexpression of multifunctional pigment epithelium-derived factor. Melanoma Res (2011) 0.80
Targeting metabolic flexibility by simultaneously inhibiting respiratory complex I and lactate generation retards melanoma progression. Oncotarget (2015) 0.79
Backbone dynamics of the human MIA protein studied by (15)N NMR relaxation: implications for extended interactions of SH3 domains. Protein Sci (2003) 0.78
Molecular dynamic simulation insights into the normal state and restoration of p53 function. Int J Mol Sci (2012) 0.78
Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients. Pigment Cell Melanoma Res (2014) 0.77
Quantitative measurement of circulating lymphoid-specific helicase (HELLS) gene transcript: a potential serum biomarker for melanoma metastasis. Pigment Cell Melanoma Res (2010) 0.76
The Neurotrophin Neuritin1 (cpg15) is involved in melanoma migration, attachment independent growth, and vascular mimicry. Oncotarget (2016) 0.75
Serum CEACAM1 Elevation Correlates with Melanoma Progression and Failure to Respond to Adoptive Cell Transfer Immunotherapy. J Immunol Res (2015) 0.75
CEACAM1: Expression and Role in Melanocyte Transformation. Dis Markers (2016) 0.75
Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I-II early-stage melanoma. Int J Cancer (2016) 0.75
Soluble NKG2D ligands are biomarkers associated with the clinical outcome to immune checkpoint blockade therapy of metastatic melanoma patients. Oncoimmunology (2017) 0.75
Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein. Oncotarget (2017) 0.75
Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med (2000) 16.30
Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer (1997) 8.27
A conserved mechanism of retrovirus restriction in mammals. Proc Natl Acad Sci U S A (2000) 4.88
p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood (1995) 4.12
Human foamy virus reverse transcription that occurs late in the viral replication cycle. J Virol (1997) 2.42
Expression of the Listeria monocytogenes EGD inlA and inlB genes, whose products mediate bacterial entry into tissue culture cell lines, by PrfA-dependent and -independent mechanisms. Infect Immun (1995) 2.34
Active and inactive genes localize preferentially in the periphery of chromosome territories. J Cell Biol (1996) 2.25
Ventricular oversensing in 518 patients with implanted cardiac defibrillators: incidence, complications, and solutions. Europace (2007) 2.08
Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia. Leukemia (2004) 2.08
Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins. J Virol (1997) 1.90
Identification of the regions of Fv1 necessary for murine leukemia virus restriction. J Virol (2001) 1.90
Phenotypic heterogeneity of cerebrospinal fluid-derived HIV-specific and HLA-restricted cytotoxic T-cell clones. Nature (1988) 1.87
High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia. Leukemia (2005) 1.72
11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood (1997) 1.69
Response to thalidomide in progressive multiple myeloma is not mediated by inhibition of angiogenic cytokine secretion. Br J Haematol (2001) 1.68
Dissemination of tumor cells in patients undergoing surgery for colorectal cancer. Clin Cancer Res (1998) 1.68
A human keratin 14 "knockout": the absence of K14 leads to severe epidermolysis bullosa simplex and a function for an intermediate filament protein. Genes Dev (1994) 1.65
Arterial spin labeling in combination with a look-locker sampling strategy: inflow turbo-sampling EPI-FAIR (ITS-FAIR). Magn Reson Med (2001) 1.65
Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup. J Clin Oncol (2004) 1.62
Laparoscopic restorative proctocolectomy. Br J Surg (2005) 1.60
Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases. Br J Cancer (2005) 1.59
Renal arteries: optimization of three-dimensional gadolinium-enhanced MR angiography with bolus-timing-independent fast multiphase acquisition in a single breath hold. Radiology (1999) 1.58
High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma. Clin Cancer Res (2001) 1.51
High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children. Blood (1994) 1.50
H-2K-restricted granuloma formation by Ly-2+ T cells in antibacterial protection to facultative intracellular bacteria. J Immunol (1985) 1.50
Changes in myocardial oxygenation and perfusion under pharmacological stress with dipyridamole: assessment using T*2 and T1 measurements. Magn Reson Med (1999) 1.48
Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children. Blood (1996) 1.46
Pilot scale production of a human monoclonal antibody against human immunodeficiency virus HIV-1. J Biochem Biophys Methods (1990) 1.46
[Reuse of "single use" medical devices after quality assured reprocessing: hygienic, legal and economic aspects. Potential for cost savings in interventional cardiology]. Z Kardiol (2002) 1.39
Regression of metastatic angiosarcoma of the skin after systemic treatment with liposome-encapsulated doxorubicin and interferon-alpha. Br J Dermatol (1999) 1.36
Dynamics of T cells of L3T4 and Ly 2 phenotype within granulomas in murine listeriosis. Clin Exp Immunol (1985) 1.33
Analysis of the T cell response to tumor and viral peptide antigens by an IFNgamma-ELISPOT assay. Int J Cancer (1997) 1.28
Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myeloma. Bone Marrow Transplant (2005) 1.27
Polymerase chain reaction-based detection of dermatophyte DNA with a fungus-specific primer system. Mycoses (1995) 1.27
A newly created splice donor site in exon 25 of the MyBP-C gene is responsible for inherited hypertrophic cardiomyopathy with incomplete disease penetrance. Circulation (2000) 1.26
Synthesis and biological evaluation of a (99m)Tc-labelled cyclic RGD peptide for imaging the alphavbeta3 expression. Nuklearmedizin (2004) 1.25
Immune escape of melanoma: first evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway. Cancer Res (2001) 1.25
Invasion and intracellular survival of Bordetella bronchiseptica in mouse dendritic cells. Infect Immun (1994) 1.23
Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer. Int J Cancer (2000) 1.22
Serotonin transporter (5-HTT) gene variants associated with autism? Hum Mol Genet (1997) 1.21
High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability. Br J Cancer (2008) 1.20
On the prognostic value of survival models with application to gene expression signatures. Stat Med (2010) 1.20
Occurrence of antibodies against chlamydial lipopolysaccharide in human sera as measured by ELISA using an artificial glycoconjugate antigen. FEMS Immunol Med Microbiol (1994) 1.20
Detection of hematogenic tumor cell dissemination in patients undergoing resection of liver metastases of colorectal cancer. Ann Surg (2000) 1.18
TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations. Leukemia (2010) 1.15
MRI of the lung (1/3): methods. Insights Imaging (2012) 1.12
Developmental interrelationship of specific Lyt 123 and Lyt 1 cell sets in expression of antibacterial immunity to Listeria monocytogenes. Infect Immun (1984) 1.11
Clinical applications of multifocal electroretinography. Doc Ophthalmol (2000) 1.11
Efficient intracellular retrotransposition of an exogenous primate retrovirus genome. EMBO J (2000) 1.11
Hip mineral density in females with a recent hip fracture. J Clin Endocrinol Metab (1992) 1.11
ECG-gated 23Na-MRI of the human heart using a 3D-radial projection technique with ultra-short echo times. MAGMA (2004) 1.10
Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia. Virchows Arch (1997) 1.10
Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis. Oncogene (2009) 1.10
Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trial. Leukemia (2003) 1.08
Patient satisfaction with transgender health services. J Sex Marital Ther (2004) 1.07
Validation of a vision-based, three-dimensional facial imaging system. Cleft Palate Craniofac J (2003) 1.07
Nuclear magnetic resonance imaging of airways in humans with use of hyperpolarized 3He. Magn Reson Med (1996) 1.07
Analysis of reelin as a candidate gene for autism. Mol Psychiatry (2003) 1.05
Comparative analysis of tumor cell dissemination in mesenteric, central, and peripheral venous blood in patients with colorectal cancer. Arch Surg (2001) 1.03
Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays. Br J Cancer (2006) 1.03
Laparoscopically assisted colectomy and ileoanal pouch procedure with and without protective ileostomy. Surg Endosc (2003) 1.03
[Computer-based training--a new method in surgical education and continuing education]. Chirurg (1997) 1.02
Centrosome amplification as a possible mechanism for numerical chromosome aberrations in cerebral primitive neuroectodermal tumors with TP53 mutations. Cytogenet Cell Genet (1998) 1.01
Testicular invasion and relapse and meningeal involvement in a rat T-cell leukaemia. Br J Cancer (1984) 1.00
Facial asymmetry--3D assessment of infants with cleft lip & palate. Int J Paediatr Dent (2003) 1.00
Theory of the BOLD effect in the capillary region: an analytical approach for the determination of T2 in the capillary network of myocardium. Magn Reson Med (1999) 1.00
Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma. Arch Surg (2000) 0.99
Analysis of chromosomal imbalances in sporadic and NF1-associated peripheral nerve sheath tumors by comparative genomic hybridization. Genes Chromosomes Cancer (1999) 0.99
Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imaging. Int J Cancer (2001) 0.99
A new way for surgical education--development and evaluation of a computer-based training module. Comput Biol Med (2000) 0.99
Estimation of aortic compliance using magnetic resonance pulse wave velocity measurement. Phys Med Biol (2000) 0.98
Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: induction of cytotoxic T cells and specific tumor protection. Int J Cancer (1999) 0.97
Cerebral arteriovenous malformations: improved nidus demarcation by means of dynamic tagging MR-angiography. Magn Reson Imaging (1996) 0.96
Detection of hematogenous micrometastasis in patients with transitional cell carcinoma. J Urol (2000) 0.96
Hematogenous tumor cell dissemination during colonoscopy for colorectal cancer. Surg Endosc (2004) 0.95
Dose-dependent regression of HeLa cell-derived tumours in SCID mice after parvovirus H-1 infection. Int J Cancer (1998) 0.95
Centrosome aberrations as a possible mechanism for chromosomal instability in non-Hodgkin's lymphoma. Leukemia (2003) 0.95
Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q. Oncogene (2007) 0.95
Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients. Ann Hematol (2003) 0.95
Comparison of laparoscopic versus conventional technique in colonic and liver resection in a tumor-bearing small animal model. Surg Endosc (2002) 0.94
Renal artery stenosis: grading of hemodynamic changes with cine phase-contrast MR blood flow measurements. Radiology (1997) 0.94
Epidermal growth factor improves lentivirus vector gene transfer into primary mouse hepatocytes. Gene Ther (2011) 0.94
Clinical use of a new transvenous atrial lead. Am J Cardiol (1977) 0.94
Elevated titers of cell-free interleukin-2 receptor in serum and cerebrospinal fluid specimens of patients with acquired immunodeficiency syndrome. Immunol Lett (1986) 0.93
Effectiveness of non-cardiac preoperative testing in non-cardiac elective surgery: a systematic review. Br J Anaesth (2013) 0.93
A comparison of a new antigen from amastigotes of Trypanosoma cruzi and an antigen from epimastigotes for the diagnosis of Chagas' disease by the indirect immunofluorescence test. Rev Inst Med Trop Sao Paulo (1971) 0.93
[S-100 beta protein in serum, a tumor marker in malignant melanoma-- current state of knowledge and clinical experience]. Hautarzt (1999) 0.93
A high risk phenotype of hypertrophic cardiomyopathy associated with a compound genotype of two mutated beta-myosin heavy chain genes. Hum Genet (1998) 0.93
BOLD-MRI in ten patients with coronary artery disease: evidence for imaging of capillary recruitment in myocardium supplied by the stenotic artery. MAGMA (1999) 0.93
Comparison of diffusion anisotropy measurements in combination with the flair-technique. Magn Reson Imaging (1999) 0.93
Evaluation of Bethesda guidelines in relation to microsatellite instability. Dis Colon Rectum (2001) 0.92
Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemia. Leukemia (1999) 0.91
Cure of Burkitt's lymphoma in severe combined immunodeficiency mice by T cells, tetravalent CD3 x CD19 tandem diabody, and CD28 costimulation. Cancer Res (2000) 0.91
The relationship between the BOLD-induced T(2) and T(2)(*): a theoretical approach for the vasculature of myocardium. Magn Reson Med (1999) 0.91